One of the treatments is called Vemurafenib. Studies conducted on a group of 675 melanoma patients have shown that the drug boosts survival rates more than chemotherapy. This drug acts by working on a faulty gene, BRAF, found in half terminally ill patients whose cancer has spread to other organs.
The other drug, called Ipilimumab, which is taken intravenously is said to increase the life expectancy of those living with advanced melanoma.
Researcher, Professor Richard Marais stated that the scientists findings were the ‘biggest breakthrough in melanoma treatment in more than 30 years.’